Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(4-METHOXYPHENOXY)ANILINE, also known as o-(p-Methoxyphenoxy)aniline, is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical agents. It is characterized by the presence of an aniline group attached to a methoxyphenoxy moiety, which contributes to its unique chemical properties and reactivity.

105901-39-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 105901-39-1 Structure
  • Basic information

    1. Product Name: 2-(4-METHOXYPHENOXY)ANILINE
    2. Synonyms: AKOS B021970;2-(4-METHOXYPHENOXY)ANILINE;ART-CHEM-BB B021970;CHEMBRDG-BB 4010418;2-(4-METHOXY-PHENOXY)-PHENYLAMINE;AKOS DM0075;UKRORGSYN-BB BBV-108347;2-(4-methoxyphenoxy)aniline(SALTDATA: HCl)
    3. CAS NO:105901-39-1
    4. Molecular Formula: C13H13NO2
    5. Molecular Weight: 215.25
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 105901-39-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 331.7°C at 760 mmHg
    3. Flash Point: 169.1°C
    4. Appearance: /
    5. Density: 1.155g/cm3
    6. Vapor Pressure: 0.000153mmHg at 25°C
    7. Refractive Index: 1.598
    8. Storage Temp.: 2-8°C
    9. Solubility: DCM
    10. CAS DataBase Reference: 2-(4-METHOXYPHENOXY)ANILINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-(4-METHOXYPHENOXY)ANILINE(105901-39-1)
    12. EPA Substance Registry System: 2-(4-METHOXYPHENOXY)ANILINE(105901-39-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 105901-39-1(Hazardous Substances Data)

105901-39-1 Usage

Uses

Used in Pharmaceutical Industry:
2-(4-METHOXYPHENOXY)ANILINE is used as an intermediate in the synthesis of inhibitors targeting cyclooxygenases and leukotriene A4 hydrolase for the development of anti-inflammatory and analgesic drugs. Its presence in these compounds allows for the modulation of key enzymes involved in the inflammatory response, providing potential therapeutic benefits for conditions such as arthritis, pain, and other inflammatory disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 105901-39-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,9,0 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 105901-39:
(8*1)+(7*0)+(6*5)+(5*9)+(4*0)+(3*1)+(2*3)+(1*9)=101
101 % 10 = 1
So 105901-39-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO2/c1-15-10-6-8-11(9-7-10)16-13-5-3-2-4-12(13)14/h2-9H,14H2,1H3

105901-39-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-METHOXYPHENOXY)ANILINE

1.2 Other means of identification

Product number -
Other names 2-Amino-4'-methoxydiphenyloxid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105901-39-1 SDS

105901-39-1Relevant articles and documents

Diphenyl ether derivatives occupy the expanded binding site of cyclohexanedione compounds at the colchicine site in tubulin by movement of the αT5 loop

Bueno, Oskia,Gargantilla, Marta,Estévez-Gallego, Juan,Martins, Solange,Díaz, J. Fernando,Camarasa, María-José,Liekens, Sandra,Pérez-Pérez, María-Jesús,Priego, Eva-María

, p. 195 - 208 (2019/03/28)

Microtubule targeting agents represent a very active arena in the development of anticancer agents. In particular, compounds binding at the colchicine site in tubulin are being deeply studied, and the structural information recently available on this binding site allows structure-directed design of new ligands. Structural comparison of our recently reported high resolution X-Ray structure of the cyclohexanedione derivative TUB075 bound to tubulin and the tubulin-DAMA-colchicine complex has revealed a conformational change in the αT5 loop. By a grid-based computational analysis of the tubulin-DAMA-colchicine binding site, we have identified a new favourable binding area in the colchicine-site that was unexplored by our lead TUB075. Thus, based on a structure-guided design, new cyclohexanedione derivatives have been synthesized and tested for tubulin binding and in cellular assays. As a result, we have identified diphenyl ether derivatives with IC50 values around 10–40 nM against three different tumor cell lines and affinity constants for tubulin similar to that of colchicine around 107 M?1. As expected, they halted the cell cycle progression at G2/M phase at concentrations as low as 0.08 μM.

Synthesis of medium-sized (6-7-6) ring compounds by iron-catalyzed dehydrogenative C-H activation/annulation

Panda, Niranjan,Mattan, Irshad,Ojha, Subhadra,Purohit, Chandra Shekhar

supporting information, p. 7861 - 7870 (2018/11/21)

In this report, we have described a FeCl3-catalyzed process involving intramolecular annulation of o-phenoxy diarylacetylenes via hydroarylation to afford a series of biologically potent fused seven-membered (6-7-6) ring compounds under mild reaction conditions. This reaction was believed to proceed through Friedel-Crafts type sequential carbometallation followed by protonation to produce phenyldibenz[b,f]oxepines. This method was also extended to synthesize seven-membered rings that are fused with coumarins.

CuI/oxalamide catalyzed couplings of (hetero)aryl chlorides and phenols for diaryl ether formation

Fan, Mengyang,Zhou, Wei,Jiang, Yongwen,Ma, Dawei

supporting information, p. 6211 - 6215 (2016/05/24)

Couplings between (hetero)aryl chlorides and phenols can be effectively promoted by CuI in combination with an N-aryl-N′-alkyl-substituted oxalamide ligand to proceed smoothly at 120 °C. For this process, N-aryl-N′-alkyl-substituted oxalamides are more effective ligands than bis(N-aryl)-substituted oxalamides. A wide range of electron-rich and electron-poor aryl and heteroaryl chlorides gave the corresponding coupling products in good yields. Satisfactory conversions were achieved with electron-rich phenols as well as a limited range of electron-poor phenols. Catalyst and ligand loadings as low as 1.5 mol % are sufficient for the scaled-up variants of some of these reactions. Aryl and alkyl: N-Aryl-N′-alkyl-substituted oxalamide ligands promote the CuI catalyzed coupling of (hetero)aryl chlorides and phenols at 120 °C more effectively than bis(N-aryl)-substituted oxalamides. A wide range of electron-rich and electron-poor aryl and heteroaryl chlorides were converted into the corresponding coupling products in good yields.

Design, synthesis and antifungal activity of novel furancarboxamide derivatives

Wen, Fang,Jin, Hong,Tao, Ke,Hou, Taiping

, p. 244 - 251 (2016/05/24)

Twenty-seven novel furancarboxamide derivatives with a diphenyl ether moiety were synthesized and evaluated for their antifungal activity against Rhizoctonia solani, Botrytis cirerea, Valsa Mali and Sphaceloma ampelimum. Antifungal bioassay results indicated that most compounds had good or excellent fungicidal activities for R. solani and S. ampelimum at 20 mg L-1. Among synthesized compounds, compound 18e showed a greater inhibitory effect against S. ampelimum, with half maximal effective concentration (EC50) values of 0.020 mg L-1. This strong activity rivals currently used commercial fungicides, such as Boscalid and Carbendazim, and has great potential as a lead compound for future development of novel fungicides.

Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents

Mishra, Amita,Batchu, Harikrishna,Srivastava, Kumkum,Singh, Pratiksha,Shukla, Pravin K.,Batra, Sanjay

supporting information, p. 1719 - 1723 (2014/04/17)

Synthesis and bioevaluation of new diaryl ether hybridized quinoline derivatives as antiplasmodial, antibacterial and antifungal agents is reported. It was encouraging to discover that several compounds displayed 2-3 folds better efficacy than chloroquine in chloroquine-resistant K1 strain of Plasmodium falciparum. Further, a few members of the library displayed good antibacterial efficacy against gram positive strains of bacteria but none of the compounds displayed any significant antifungal activity.

Additivity of substituent effects in aromatic stacking interactions

Hwang, Jungwun,Li, Ping,Carroll, William R.,Smith, Mark D.,Pellechia, Perry J.,Shimizu, Ken D.

supporting information, p. 14060 - 14067 (2015/01/08)

The goal of this study was to experimentally test the additivity of the electrostatic substituent effects (SEs) for the aromatic stacking interaction. The additivity of the SEs was assessed using a small molecule model system that could adopt an offset face-to-face aromatic stacking geometry. The intramolecular interactions of these molecular torsional balances were quantitatively measured via the changes in a folded/unfolded conformational equilibrium. Five different types of substituents were examined (CH3, OCH3, Cl, CN, and NO2) that ranged from electron-donating to electron-withdrawing. The strength of the intramolecular stacking interactions was measured for 21 substituted aromatic stacking balances and 21 control balances in chloroform solution. The observed stability trends were consistent with additive SEs. Specifically, additive SE models could predict SEs with an accuracy from ±0.01 to ±0.02 kcal/mol. The additive SEs were consistent with Wheeler and Houk's direct SE model. However, the indirect or polarization SE model cannot be ruled out as it shows similar levels of additivity for two to three substituent systems, which were the number of substituents in our model system. SE additivity also has practical utility as the SEs can be accurately predicted. This should aid in the rational design and optimization of systems that utilize aromatic stacking interactions.

Synthesis of tetrasubstituted alkenes through a palladium-catalyzed domino carbopalladation/C-H-activation reaction

Tietze, Lutz F.,Hungerland, Tim,Duefert, Alexander,Objartel, Ina,Stalke, Dietmar

supporting information; experimental part, p. 3286 - 3291 (2012/04/17)

Helical tetrasubstituted alkenes (7) were obtained in a highly efficient way through a palladium-catalyzed domino-carbopalladation/CH-activation reaction of propargylic alcohols 6 in good to excellent yields. Electron-withdrawing- and electron-donating substituents can be introduced onto the upper and lower aromatic rings. The substrates (6) for the domino process were synthesized by addition of the lithiated alkyne (20) to various aldehydes (19); moreover, the substrates were accessible enantioselectively (in 95 % ee) by reduction of the corresponding ketone using the Noyori procedure. Copyright

Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase

Chen, Zheng,Wu, Yiran,Liu, Ying,Yang, Suijia,Chen, Yunjie,Lai, Luhua

experimental part, p. 3650 - 3660 (2011/07/08)

Dual target inhibitors against COX-2 and LTA4H were designed by adding functional groups from a marketed COX-2 inhibitor, Nimesulide, to an existing LTA4H inhibitor 1-(2-(4-phenoxyphenoxy) ethyl) pyrrolidine. A series of phenoxyphenyl pyrrolidine compounds were synthesized and tested for their inhibition activities using enzyme assays and human whole blood assay. Introduction of small electron withdrawing groups like NO2 and CF3 in the ortho-position of the terminal phenyl ring was found to change the original single target LTA4H inhibitor to dual target LTA4H and COX-2 inhibitors. Compound 5a and 5m showed dual LTA 4H and COX-2 inhibition activities in the enzyme assays and the HWB assay with IC50 values in the micromolar to submicromolar range. As their activities in HWB assay were comparable to the two starting single target inhibitors, the two compounds are promising for further studies. The strategy used in the current study may be generally applicable to other dual target drug designs.

4-NITRO-2- (4 -METHOXY)-PHENOXY -METHANESULFONANILIDE DERIVATES AND THEIR PHARMACEUTICAL USE

-

Page/Page column 4, (2008/06/13)

The present invention discloses 4-nitro-2-[(4'methoxy)-phenoxy] -methanesulfonyl aniline, or pharmaceutically acceptable salts, solvates or hydrates thereof, or mixtures thereof with povidone, phospholipid or cyclodextrin, and their pharmaceutical uses, e

A total synthesis of 4-hydroxynimesulide

Singh, Parmjeet,Singh, Amarjit,Sharma

, p. 1263 - 1264 (2007/10/03)

4-Hydroxynimesulide, a unique metabolite of Nimesulide has been synthesized by the formation of 4-methoxynimesulide and its subsequent demethylation with aq. HBr-AcOH/anhyd. AlCl3-CH2Cl2.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105901-39-1